Press Releases Aug 11, 2026 Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award Aug 05, 2026 Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress Jun 18, 2026 Nortiva Bio Launches to Develop Long-Acting Oral Medicines View all press releases Presentations & Events View all presentations & events Form 8937 View Form 8937 - September 30, 2015 View Form 8937
Aug 11, 2026 Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Aug 05, 2026 Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress